# Use of CGM in Kidney Transplant Recipients

> **NCT04783441** · NA · RECRUITING · sponsor: **University of California, Davis** · enrollment: 80 (estimated)

## Conditions studied

- Kidney Transplant; Complications
- Diabetes Mellitus, Type 2
- Insulin Dependent Diabetes

## Interventions

- **DEVICE:** Dexcom G6
- **DEVICE:** Dexcom G6 blinded sensor

## Key facts

- **NCT ID:** NCT04783441
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-29
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04783441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04783441, "Use of CGM in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04783441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*